| 4:00–8:00 PM | Registration | Longs Peak Foyer |
| 6:00–8:00 PM | Welcome Mixer | Longs Peak Foyer |
| 7:00–8:00 AM | Breakfast | Quandary Peak |
| 8:00–8:10 AM | Welcome Remarks | Longs Peak |
| 8:10–9:00 AM | Keynote Address | Longs Peak |
| Carine Boustany, Boehringer Ingelheim Drug Discovery in Fibrosis |
| 9:00–11:15 AM | Developing Novel Therapeutics in Fibrotic Disease | Longs Peak |
| Thomas A Wynn, Pfizer Anti-Inflammatory Therapeutics in Organ Fibrosis |
| Paul J Yaworsky, Mediar Therapeutics Targeting EphrinB2 and SMOC2 in Fibrotic Disease |
| Catherine Hines, GlaxoSmithKline Biomarkers and Imaging as Readouts in Clinical Testing |
| Short Talk(s) Chosen from Abstracts |
| 9:30–9:50 AM | Coffee Break | Longs Peak Foyer |
| 11:15–11:20 AM | Jessica Langer, Helmsley Trust Introduction | Longs Peak |
| 11:25–12:25 PM | Meet the Editors | Longs Peak |
| 12:25–1:00 PM | Poster Setup | Quandary Peak |
| 12:25–2:30 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing | Quandary Peak |
| 2:30–4:30 PM | Symposia Spotlight 1 | Longs Peak |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00–7:00 PM | From Identification of Novel Therapies to Early Clinical Testing in Fibrosis | Longs Peak |
| Rachel Lennon, University of Manchester Novel Therapies for Scarring of the Glomerulus |
| Rebekka Schneider, Erasmus MC From Single Cell Genomics to Novel Targets in Fibrotic Disease and Clinical Testing |
| Frank A Anania, US Food and Drug Administration Regulatory Steps Towards Approval of Novel Antifibrotic Therapies |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner | Quandary Peak |
| 7:30–10:00 PM | Poster Session 1 | Quandary Peak |
| 7:00–8:00 AM | Breakfast | Quandary Peak |
| 8:00–11:00 AM | Mapping Fibrotic Disease using Single Cell and Spatial Genomics | Longs Peak |
| Rafael Kramann, RWTH Aachen University Mapping Kidney and Cardiac Fibrosis to Identify Novel Therapeutic Targets |
| Neil C. Henderson, Institute of Regeneration and Repair, University of Edinburgh Spatial Mapping of Human Liver Fibrosis |
| Jörg H Distler, University Hospital Düsseldorf Mapping Pulmonary and Skin Fibrosis |
| Benjamin D. Humphreys, Washington University Single Cell and Spatial Genomics to Map Kidney Fibrosis |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break | Longs Peak Foyer |
| 11:10–12:10 PM | Panel Discussion 1: How to Launch a Startup | Longs Peak |
| Rafael Kramann, RWTH Aachen University |
| Rebekka Schneider, Erasmus MC |
| Neil C. Henderson, Institute of Regeneration and Repair, University of Edinburgh |
| Paul J Yaworsky, Mediar Therapeutics |
| 12:10–1:00 PM | Poster Setup | Quandary Peak |
| 12:10–3:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing | Quandary Peak |
| 3:00–4:30 PM | Career Roundtable | Longs Peak |
| 4:30–5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00–7:00 PM | Fibrosis in Cancer and Aging | Longs Peak |
| Natalie J. Torok, Stanford University The Role of Matrix in Liver Cancer Progression and Aging |
| Simón Méndez-Ferrer, University of Cambridge Mechanisms of Fibrosis Hematopoietic Malignancies |
| Melanie Koenigshoff, University of Pittsburgh Role of Senescence and Aging in Pulmonary Fibrosis |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner | Quandary Peak |
| 7:30–10:00 PM | Poster Session 2 | Quandary Peak |
| 7:00–8:00 AM | Breakfast | Quandary Peak |
| 8:00–11:00 AM | Organ Specific and Conserved Mechanisms of Organ Fibrosis | Longs Peak |
| Valerie Horsley, Yale University Mechanisms of Skin Fibrosis |
| Meritxell Huch, Max Planck Institute of Molecular Cell Biology and Genetics Modeling Fibrosis ex vivo |
| Katalin Susztak, University of Pennsylvania Mechanisms of Kidney Fibrosis |
| Kory J. Lavine, Washington University School of Medicine Mechanisms of Cardiac Fibrosis |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break | Longs Peak Foyer |
| 11:10–12:10 PM | Panel Discussion 2: Why Are We not Seeing Progress / Therapeutic Success in Some Areas? What Are We Missing and How can We Address these Challenges/ Lessons from Clinical Trials? | Longs Peak |
| 12:10–2:30 PM | On Own for Lunch |
| 2:30–4:30 PM | Symposia Spotlight 2: AI & Big Data in Drug Development | Longs Peak |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available | Longs Peak Foyer |
| 5:00–6:45 PM | Need for Multimodal Therapies, New Modalities and Lessons Learned from Clinical Trials | Longs Peak |
| Grant Budas, Gilead Multimodal Therapies for Fibrotic Disease |
| Vincent F Fiore, Boehringer Ingelheim Mechanisms of Fibrosis in IBD, Boehringer Ingelheim |
| Scott L Friedman, Icahn School of Medicine at Mount Sinai Lessons Learned from Clinical Trials and Regulatory Aspects in Fibrotic Disease |
| Short Talk(s) Chosen from Abstracts |
| 6:45–7:00 PM | Meeting Wrap-Up: Outcomes and Future Directions (Organizers) | Longs Peak |
| 7:00–8:00 PM | Social Hour with Dinner | Quandary Peak |
| 8:00–9:00 PM | Entertainment | Quandary Peak |
| 8:00–9:00 PM | Cash Bar | Quandary Peak |
| 12:00–11:59 PM | Departure |